Acurx Pharmaceuticals Q3 EPS $(0.49) Misses $(0.39) Estimate
Benzinga Newsdesk 1 week ago
NewsEarningsEarnings Misses
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Acurx Pharmaceuticals (NASDAQ:ACXP) reported quarterly losses of $(0.49) per share which missed the analyst consensus estimate of $(0.39) by 25.64 percent. This is a 60.16 percent increase over losses of $(1.23) per
Acurx Pharmaceuticals (NASDAQ:ACXP) reported quarterly losses of $(0.49) per share which missed the analyst consensus estimate of $(0.39) by 25.64 percent. This is a 60.16 percent increase over losses of $(1.23) per share from the same period last year.
